SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Statements Of Operations) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
License and R&D Services [Member]
Revenues	$ 25,262	$ 1,836
Goods [Member]
Revenues	8,978	19,242	$ 9,199
Pfizer [Member] | Goods [Member]
Revenues	5,320	12,181	5,226
BRAZIL | Goods [Member]
Revenues	$ 3,658	$ 7,061	$ 3,973